Dykens JA, Moos WH, Howell N.
Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study.
Ann N Y Acad Sci. 2005 Jun;1052:116-35.
Please login to recommend the paper.
No Available Comments
To make a comment you must login or register.